STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Valneva SE updates Form F-3 via 6-K Q3 2025 results

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Valneva SE filed a Form 6-K reporting that it has released its results for the three months ended September 30, 2025. The company furnished a press release and unaudited interim condensed consolidated financial statements as exhibits, providing more detail on its recent quarterly performance.

Most of the information in this Form 6-K, excluding the section titled “Financial Outlook” in the press release, is incorporated by reference into Valneva’s existing Form F-3 registration statement. This means those disclosures can now be used in connection with Valneva’s registered securities offerings in the United States.

Positive

  • None.

Negative

  • None.



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report: November 20, 2025

Commission File Number: 001-40377

Valneva SE
(Translation of registrant's name into English)

6 rue Alain Bombard
44800 Saint-Herblain, France
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐


On November 20, 2025, the Registrant announced its results for the three months ended September 30, 2025 and issued a press release and unaudited interim condensed consolidated financial statements, copies of which are attached hereto as Exhibits 99.1, and 99.2, respectively. The information contained in this Form 6-K, but excluding the section entitled “Financial Outlook” in Exhibit 99.1, is hereby incorporated by reference into the registrant's Registration Statement on Form F-3 (File No. 333-268071).

Exhibit
Exhibit 99.1
Press release dated November 20, 2025
Exhibit 99.2
Unaudited Interim Condensed Consolidated Financial Statements as at September 30, 2025 and for the three months ended September 30, 2025











SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Valneva SE (Registrant)
Date: November 20, 2025
/s/ Thomas Lingelbach
Thomas Lingelbach
Chief Executive Officer and President



FAQ

What did Valneva SE (VALN) report in this Form 6-K?

Valneva SE reported that it has announced its results for the three months ended September 30, 2025 and furnished a press release and unaudited interim condensed consolidated financial statements as exhibits.

Which financial period does Valneva SE’s November 20, 2025 Form 6-K cover?

The Form 6-K relates to Valneva SE’s results for the three months ended September 30, 2025 and includes financial statements as of that date.

What documents are attached to Valneva SE’s Form 6-K for November 20, 2025?

The filing includes Exhibit 99.1, a press release dated November 20, 2025, and Exhibit 99.2, unaudited interim condensed consolidated financial statements as at September 30, 2025 and for the three months then ended.

How does this Form 6-K affect Valneva SE’s Form F-3 registration statement?

The information in this Form 6-K, excluding the “Financial Outlook” section in the press release, is incorporated by reference into Valneva SE’s Form F-3 registration statement (File No. 333-268071).

Who signed Valneva SE’s November 20, 2025 Form 6-K?

The Form 6-K was signed on behalf of Valneva SE by Thomas Lingelbach, who is the company’s Chief Executive Officer and President.
Valneva Se

NASDAQ:VALN

VALN Rankings

VALN Latest News

VALN Latest SEC Filings

VALN Stock Data

819.65M
83.57M
5.57%
0.02%
Biotechnology
Healthcare
Link
France
Saint-Herblain